Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. (Q48527134)
Jump to navigation
Jump to search
scientific article published in November 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. |
scientific article published in November 1995 |
Statements
1 reference
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. (English)
1 reference
Liberman UA
1 reference
Weiss SR
1 reference
Bröll J
1 reference
Minne HW
1 reference
Quan H
1 reference
Bell NH
1 reference
Rodriguez-Portales J
1 reference
Downs RW Jr
1 reference
Dequeker J
1 reference
Favus M
1 reference
1 November 1995
1 reference
1 reference
333
1 reference
1437-1443
1 reference
22
1 reference
Identifiers
1 reference
1 reference